BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29921494)

  • 1. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
    Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
    Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clincopathological analysis of olfactory neuroblastoma.
    Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
    Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
    Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
    APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
    Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
    Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
    Taraszewska A; Czorniuk-Sliwa A; Dambska M
    Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
    Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
    Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
    Czapiewski P; Kunc M; Haybaeck J
    Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathologic features of olfactory neuroblastoma.
    Mahooti S; Wakely PE
    Cancer; 2006 Apr; 108(2):86-92. PubMed ID: 16456848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
    Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B
    Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.
    Meyer C; Hamersley ERS; Manosalva RE; Torske K; McIntyre N; Mitchell A
    Head Neck Pathol; 2017 Dec; 11(4):531-536. PubMed ID: 28168398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
    Yao Q; Yue CL; Lü ZC; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):163-8. PubMed ID: 19575850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
    Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
    Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic primary olfactory neuroblastoma of the maxillary sinus.
    Holmes M; Su SY; Bell D
    Ann Diagn Pathol; 2016 Jun; 22():45-8. PubMed ID: 27180059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcome in 12 cases of olfactory neuroblastoma at Mexico´s National Cancer Institute: A retrospective clinical analysis and literature review.
    Navarro-Fernández JO; Serrato-Avila JL; Hernández-Varela M; Tejada-Pineda MF; Hernández-Reséndiz RE; Monroy-Sosa A; Cacho-Díaz B; Herrera-Gómez Á; Reyes-Soto G
    Cir Cir; 2020; 88(4):453-460. PubMed ID: 32567594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
    Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
    Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.